{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:50:22Z","timestamp":1793058622331,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    T cell senescence and exhaustion are major barriers to successful cancer immunotherapy. Here we show that miR-155 increases CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell antitumor function by restraining T cell senescence and functional exhaustion through epigenetic silencing of drivers of terminal differentiation. miR-155 enhances Polycomb repressor complex 2 (PRC2) activity indirectly by promoting the expression of the PRC2-associated factor Phf19 through downregulation of the Akt inhibitor, Ship1. Phf19 orchestrates a transcriptional program extensively shared with miR-155 to restrain T cell senescence and sustain CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell antitumor responses. These effects rely on Phf19 histone-binding capacity, which is critical for the recruitment of PRC2 to the target chromatin. These findings establish the miR-155\u2013Phf19\u2013PRC2 as a pivotal axis regulating CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell differentiation, thereby paving new ways for potentiating cancer immunotherapy through epigenetic reprogramming of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell fate.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-09882-8","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T06:04:05Z","timestamp":1557813845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6340-7009","authenticated-orcid":false,"given":"Yun","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6263-4306","authenticated-orcid":false,"given":"Jessica","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuoqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-5924","authenticated-orcid":false,"given":"Neal E.","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjivan","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Le Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Hocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma M.","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-2820","authenticated-orcid":false,"given":"Stefania","family":"Dell\u2019Orso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga V.","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Telford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-6228","authenticated-orcid":false,"given":"Luciano","family":"Di Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A.","family":"Muljo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Sartorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2239-3282","authenticated-orcid":false,"given":"Luca","family":"Gattinoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"9882_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","volume":"35","author":"A Schietinger","year":"2014","unstructured":"Schietinger, A. & Greenberg, P. D. Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol. 35, 51\u201360 (2014).","journal-title":"Trends Immunol."},{"key":"9882_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrc3322","volume":"12","author":"L Gattinoni","year":"2012","unstructured":"Gattinoni, L., Klebanoff, C. A. & Restifo, N. P. Paths to stemness: building the ultimate antitumour T cell. Nat. Rev. Cancer 12, 671\u2013684 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"9882_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm.1982","volume":"15","author":"L Gattinoni","year":"2009","unstructured":"Gattinoni, L. et al. Wnt signaling arrests effector T cell differentiation and generates CD8\u2009+\u2009memory stem cells. Nat. Med. 15, 808\u2013813 (2009).","journal-title":"Nat. Med."},{"key":"9882_CR4","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ni.2153","volume":"12","author":"Y Ji","year":"2011","unstructured":"Ji, Y. et al. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8\u2009+\u2009T cells. Nat. Immunol. 12, 1230\u20131237 (2011).","journal-title":"Nat. Immunol."},{"key":"9882_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41590-018-0311-z","volume":"20","author":"S Gautam","year":"2019","unstructured":"Gautam, S. et al. The transcription factor c-Myb regulates CD8(+) T cell stemness and antitumor immunity. Nat. Immunol. 20, 337\u2013349 (2019).","journal-title":"Nat. Immunol."},{"key":"9882_CR6","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1172\/JCI69589","volume":"123","author":"M Sukumar","year":"2013","unstructured":"Sukumar, M. et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Investig. 123, 4479\u20134488 (2013).","journal-title":"J. Clin. Investig."},{"key":"9882_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer cell 27, 450\u2013461 (2015).","journal-title":"Cancer cell"},{"key":"9882_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.smim.2015.11.006","volume":"28","author":"Y Ji","year":"2016","unstructured":"Ji, Y., Hocker, J. D. & Gattinoni, L. Enhancing adoptive T cell immunotherapy with microRNA therapeutics. Semin. Immunol. 28, 45\u201353 (2016).","journal-title":"Semin. Immunol."},{"key":"9882_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri.2016.40","volume":"16","author":"A Mehta","year":"2016","unstructured":"Mehta, A. & Baltimore, D. MicroRNAs as regulatory elements in immune system logic. Nat. Rev. Immunol. 16, 279\u2013294 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"9882_CR10","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1742-4658.2011.08089.x","volume":"278","author":"F Sato","year":"2011","unstructured":"Sato, F., Tsuchiya, S., Meltzer, S. J. & Shimizu, K. MicroRNAs and epigenetics. FEBS J. 278, 1598\u20131609 (2011).","journal-title":"FEBS J."},{"key":"9882_CR11","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.1073\/pnas.0707628104","volume":"104","author":"M Fabbri","year":"2007","unstructured":"Fabbri, M. et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104, 15805\u201315810 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9882_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1725","volume":"38","author":"JF Chen","year":"2006","unstructured":"Chen, J. F. et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet 38, 228\u2013233 (2006).","journal-title":"Nat. Genet"},{"key":"9882_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcel.2009.08.008","volume":"36","author":"AH Juan","year":"2009","unstructured":"Juan, A. H., Kumar, R. M., Marx, J. G., Young, R. A. & Sartorelli, V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell 36, 61\u201374 (2009).","journal-title":"Mol. Cell"},{"key":"9882_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ni.3313","volume":"17","author":"E Zhao","year":"2016","unstructured":"Zhao, E. et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat. Immunol. 17, 95\u2013103 (2016).","journal-title":"Nat. Immunol."},{"key":"9882_CR15","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2012.12.006","volume":"38","author":"JC Dudda","year":"2013","unstructured":"Dudda, J. C. et al. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 38, 742\u2013753 (2013).","journal-title":"Immunity"},{"key":"9882_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ni.2576","volume":"14","author":"DT Gracias","year":"2013","unstructured":"Gracias, D. T. et al. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat. Immunol. 14, 593\u2013602 (2013).","journal-title":"Nat. Immunol."},{"key":"9882_CR17","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.4049\/jimmunol.1202700","volume":"190","author":"EF Lind","year":"2013","unstructured":"Lind, E. F., Elford, A. R. & Ohashi, P. S. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J. Immunol. 190, 1210\u20131216 (2013).","journal-title":"J. Immunol."},{"key":"9882_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1073\/pnas.1422916112","volume":"112","author":"Y Ji","year":"2015","unstructured":"Ji, Y. et al. miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic gammac cytokines. Proc. Natl Acad. Sci. USA 112, 476\u2013481 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9882_CR19","doi-asserted-by":"publisher","first-page":"e1026533","DOI":"10.1080\/2162402X.2015.1026533","volume":"4","author":"Y Ji","year":"2015","unstructured":"Ji, Y. & Gattinoni, L. miR-155 releases the brakes on antitumor T cells. Oncoimmunology 4, e1026533 (2015).","journal-title":"Oncoimmunology"},{"key":"9882_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature06008","volume":"448","author":"TS Mikkelsen","year":"2007","unstructured":"Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553\u2013560 (2007).","journal-title":"Nature"},{"key":"9882_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet 40, 499\u2013507 (2008).","journal-title":"Nat. Genet"},{"key":"9882_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrg3607","volume":"15","author":"T Chen","year":"2014","unstructured":"Chen, T. & Dent, S. Y. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat. Rev. Genet 15, 93\u2013106 (2014).","journal-title":"Nat. Rev. Genet"},{"key":"9882_CR23","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.celrep.2018.04.038","volume":"23","author":"E Stelekati","year":"2018","unstructured":"Stelekati, E. et al. Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155. Cell Rep. 23, 2142\u20132156 (2018).","journal-title":"Cell Rep."},{"key":"9882_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"9882_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/2326-6066.CIR-15-0178","volume":"4","author":"AL Doedens","year":"2016","unstructured":"Doedens, A. L. et al. Molecular programming of tumor-infiltrating CD8+ T cells and IL15 resistance. Cancer Immunol. Res 4, 799\u2013811 (2016).","journal-title":"Cancer Immunol. Res"},{"key":"9882_CR26","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.15252\/embj.201490786","volume":"34","author":"M Giordano","year":"2015","unstructured":"Giordano, M. et al. Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion. EMBO J. 34, 2042\u20132058 (2015).","journal-title":"EMBO J."},{"key":"9882_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.2834","volume":"15","author":"M Kurachi","year":"2014","unstructured":"Kurachi, M. et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat. Immunol. 15, 373\u2013383 (2014).","journal-title":"Nat. Immunol."},{"key":"9882_CR28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man, K. et al. Transcription factor IRF4 promotes CD8(+) T cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity 47, 1129\u20131141 (2017). e1125.","journal-title":"Immunity"},{"key":"9882_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"9882_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/ni.2158","volume":"12","author":"CY Yang","year":"2011","unstructured":"Yang, C. Y. et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat. Immunol. 12, 1221\u20131229 (2011).","journal-title":"Nat. Immunol."},{"key":"9882_CR31","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M. A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"9882_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2009.05.014","volume":"31","author":"RL Rutishauser","year":"2009","unstructured":"Rutishauser, R. L. et al. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31, 296\u2013308 (2009).","journal-title":"Immunity"},{"key":"9882_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2009.06.021","volume":"31","author":"A Kallies","year":"2009","unstructured":"Kallies, A., Xin, A., Belz, G. T. & Nutt, S. L. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 31, 283\u2013295 (2009).","journal-title":"Immunity"},{"key":"9882_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2009.06.019","volume":"31","author":"H Shin","year":"2009","unstructured":"Shin, H. et al. A role for the transcriptional repressor Blimp-1 in CD8(\u2009+\u2009) T cell exhaustion during chronic viral infection. Immunity 31, 309\u2013320 (2009).","journal-title":"Immunity"},{"key":"9882_CR35","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1084\/jem.20150194","volume":"212","author":"KD Omilusik","year":"2015","unstructured":"Omilusik, K. D. et al. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection. J. Exp. Med. 212, 2027\u20132039 (2015).","journal-title":"J. Exp. Med."},{"key":"9882_CR36","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1084\/jem.20150186","volume":"212","author":"CX Dominguez","year":"2015","unstructured":"Dominguez, C. X. et al. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J. Exp. Med. 212, 2041\u20132056 (2015).","journal-title":"J. Exp. Med."},{"key":"9882_CR37","doi-asserted-by":"crossref","unstructured":"Chen J., et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature. 567, 530\u2013534 (2019).","DOI":"10.1038\/s41586-019-0985-x"},{"key":"9882_CR38","doi-asserted-by":"publisher","first-page":"e1500737","DOI":"10.1126\/sciadv.1500737","volume":"1","author":"S Aranda","year":"2015","unstructured":"Aranda, S., Mas, G. & Di Croce, L. Regulation of gene transcription by Polycomb proteins. Sci. Adv. 1, e1500737 (2015).","journal-title":"Sci. Adv."},{"key":"9882_CR39","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.immuni.2014.03.014","volume":"40","author":"TM Escobar","year":"2014","unstructured":"Escobar, T. M. et al. miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity 40, 865\u2013879 (2014).","journal-title":"Immunity"},{"key":"9882_CR40","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nsmb.2434","volume":"19","author":"C Ballare","year":"2012","unstructured":"Ballare, C. et al. Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity. Nat. Struct. Mol. Biol. 19, 1257\u20131265 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"9882_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nsmb.2449","volume":"19","author":"GL Brien","year":"2012","unstructured":"Brien, G. L. et al. Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation. Nat. Struct. Mol. Biol. 19, 1273\u20131281 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"9882_CR42","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4161\/cc.20095","volume":"11","author":"S Ghislin","year":"2012","unstructured":"Ghislin, S., Deshayes, F., Middendorp, S., Boggetto, N. & Alcaide-Loridan, C. PHF19 and Akt control the switch between proliferative and invasive states in melanoma. Cell Cycle 11, 1634\u20131645 (2012).","journal-title":"Cell Cycle"},{"key":"9882_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2011.05.017","volume":"35","author":"EE West","year":"2011","unstructured":"West, E. E. et al. Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load. Immunity 35, 285\u2013298 (2011).","journal-title":"Immunity"},{"key":"9882_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2010.06.014","volume":"33","author":"TC Wirth","year":"2010","unstructured":"Wirth, T. C. et al. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33, 128\u2013140 (2010).","journal-title":"Immunity"},{"key":"9882_CR45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103\u2013107 (2009).","journal-title":"Nature"},{"key":"9882_CR46","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1101\/gad.267930.115","volume":"29","author":"GL Brien","year":"2015","unstructured":"Brien, G. L. et al. A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence. Genes Dev. 29, 2231\u20132243 (2015).","journal-title":"Genes Dev."},{"key":"9882_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.molcel.2012.11.026","volume":"49","author":"L Cai","year":"2013","unstructured":"Cai, L. et al. An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting. Mol. Cell 49, 571\u2013582 (2013).","journal-title":"Mol. Cell"},{"key":"9882_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nm.4241","volume":"23","author":"L Gattinoni","year":"2017","unstructured":"Gattinoni, L., Speiser, D. E., Lichterfeld, M. & Bonini, C. T memory stem cells in health and disease. Nat. Med. 23, 18\u201327 (2017).","journal-title":"Nat. Med."},{"key":"9882_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ni.3688","volume":"18","author":"B Kakaradov","year":"2017","unstructured":"Kakaradov, B. et al. Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA sequencing. Nat. Immunol. 18, 422\u2013432 (2017).","journal-title":"Nat. Immunol."},{"key":"9882_CR50","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2017.03.012","volume":"46","author":"SM Gray","year":"2017","unstructured":"Gray, S. M., Amezquita, R. A., Guan, T., Kleinstein, S. H. & Kaech, S. M. Polycomb repressive complex 2-mediated chromatin repression guides effector CD8\u2009+\u2009T cell terminal differentiation and loss of multipotency. Immunity 46, 596\u2013608 (2017).","journal-title":"Immunity"},{"key":"9882_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02187-8","volume":"8","author":"S He","year":"2017","unstructured":"He, S. et al. Ezh2 phosphorylation state determines its capacity to maintain CD8(+) T memory precursors for antitumor immunity. Nat. Commun. 8, 2125 (2017).","journal-title":"Nat. Commun."},{"key":"9882_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-immunol-032414-112014","volume":"34","author":"VR Buchholz","year":"2016","unstructured":"Buchholz, V. R., Schumacher, T. N. & Busch, D. H. T. Cell fate at the single-cell level. Annu Rev. Immunol. 34, 65\u201392 (2016).","journal-title":"Annu Rev. Immunol."},{"key":"9882_CR53","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.it.2015.09.004","volume":"36","author":"J Arsenio","year":"2015","unstructured":"Arsenio, J., Metz, P. J. & Chang, J. T. Asymmetric cell division in T lymphocyte fate diversification. Trends Immunol. 36, 670\u2013683 (2015).","journal-title":"Trends Immunol."},{"key":"9882_CR54","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature20165","volume":"540","author":"PA Tyrakis","year":"2016","unstructured":"Tyrakis, P. A. et al. S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature 540, 236\u2013241 (2016).","journal-title":"Nature"},{"key":"9882_CR55","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2014.11.001","volume":"41","author":"BE Russ","year":"2014","unstructured":"Russ, B. E. et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation. Immunity 41, 853\u2013865 (2014).","journal-title":"Immunity"},{"key":"9882_CR56","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/cmi.2015.32","volume":"13","author":"JG Crompton","year":"2016","unstructured":"Crompton, J. G. et al. Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape. Cell Mol. Immunol. 13, 502\u2013513 (2016).","journal-title":"Cell Mol. Immunol."},{"key":"9882_CR57","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fimmu.2018.00549","volume":"9","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Ezh2 regulates activation-induced CD8(+) T cell cycle progression via repressing Cdkn2a and Cdkn1c expression. Front. Immunol. 9, 549 (2018).","journal-title":"Front. Immunol."},{"key":"9882_CR58","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ncb3533","volume":"19","author":"T Celia-Terrassa","year":"2017","unstructured":"Celia-Terrassa, T. et al. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis. Nat. Cell Biol. 19, 711\u2013723 (2017).","journal-title":"Nat. Cell Biol."},{"key":"9882_CR59","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"9882_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"9882_CR61","doi-asserted-by":"crossref","unstructured":"Chen, Y., Lun, A. T. L., Smyth, G. K. Differential Expression Analysis of Complex RNA-seq Experiments Using edgeR. In Statistical Analysis of Next Generation Sequencing Data (eds. Datta, S., & Nettleton, D.) 51\u201374 (Springer International Publishing, 2014).","DOI":"10.1007\/978-3-319-07212-8_3"},{"key":"9882_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"9882_CR63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9882_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4939-0512-6_5","volume":"1150","author":"S Xu","year":"2014","unstructured":"Xu, S., Grullon, S., Ge, K. & Peng, W. Spatial clustering for identification of ChIP-enriched regions (SICER) to map regions of histone methylation patterns in embryonic stem cells. Methods Mol. Biol. 1150, 97\u2013111 (2014).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09882-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T18:36:17Z","timestamp":1671215777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09882-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9882"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09882-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.J. and L.G. are the inventors of an international pending patent on Phf19 technology (\u201cT-CELLS MODIFIED TO OVEREXPRESS PHF19\u201d PCT\/US2018\/036125 filed on 05 June 2018, applied by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICE; Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, Maryland 20892\u20137660, US). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2157"}}